Biomarkers in Urologic Cancer, An Issue of Urologic Clinics of North America, 1st Edition
著者 :
By Kevin R. Loughlin, MD, MBA
The past decade has been marked by the acceleration of our understanding of the molecular biology of cancer. Simultaneously, there have been increasing exigencies to diagnose, treat and follow cancer patients more economically. Biomarkers represent t
...view more
The past decade has been marked by the acceleration of our understanding of the molecular biology of cancer. Simultaneously, there have been increasing exigencies to diagnose, treat and follow cancer patients more economically. Biomarkers represent the marriage of science and economics. Biomarkers offer the potential to increase the precision of diagnosis, prognosis, and surveillance of urological malignancies. This issue presents the cutting-edge advances of biomarker technology to urologic oncology.
The past decade has been marked by the acceleration of our understanding of the molecular biology of cancer. Simultaneously, there have been increasing exigencies to diagnose, treat and follow cancer patients more economically. Biomarkers represent the marriage of science and economics. Biomarkers offer the potential to increase the precision of diagnosis, prognosis, and surveillance of urological malignancies. This issue presents the cutting-edge advances of biomarker technology to urologic oncology.
著者情報
By Kevin R. Loughlin, MD, MBA, Emeritus Professor of Surgery (Urology), Harvard Medical School, Visiting Scientist, Vascular Biology Research Program at Boston Children’s Hospita
By Kevin R. Loughlin, MD, MBA, Emeritus Professor of Surgery (Urology), Harvard Medical School, Visiting Scientist, Vascular Biology Research Program at Boston Children’s Hospita
https://shop.elsevier.jp/biomarkers-in-urologic-cancer-an-issue-of-urologic-clinics-of-north-america-9780323417198.html302348Biomarkers in Urologic Cancer, An Issue of Urologic Clinics of North Americahttps://secure-ecsd.elsevier.com/covers/80/Tango2/large/9780323417198.jpg1255812558JPYInStock/Medicine & Surgery/Urology/eBooks/Medicine/Urology/eBooks/eBooks/Medicine/Urology/Medicine/Urology/Product Format/E-Book/Product Format/E-Book/Product Format/E-Book/Product Format/E-Book443121343887245054618505466552550405259905580359459368005936822593682759368321418269243350884886536505455351451205259833579989258035265936799593680959368235936828The past decade has been marked by the acceleration of our understanding of the molecular biology of cancer. Simultaneously, there have been increasing exigencies to diagnose, treat and follow cancer patients more economically. Biomarkers represent the marriage of science and economics. Biomarkers offer the potential to increase the precision of diagnosis, prognosis, and surveillance of urological malignancies. This issue presents the cutting-edge advances of biomarker technology to urologic oncology. The past decade has been marked by the acceleration of our understanding of the molecular biology of cancer. Simultaneously, there have been increasing exigencies to diagnose, treat and follow cancer patients more economically. Biomarkers represent the marriage of science and economics. Biomarkers offer the potential to increase the precision of diagnosis, prognosis, and surveillance of urological malignancies. This issue presents the cutting-edge advances of biomarker technology to urologic oncology.00add-to-cart97803234171982016専門医By Kevin R. Loughlin, MD, MBA20161E-BookElsevier02016/01/19IN STOCKBy <STRONG>Kevin R. Loughlin</STRONG>, MD, MBA, Emeritus Professor of Surgery (Urology), Harvard Medical School, Visiting Scientist, Vascular Biology Research Program at Boston Children’s HospitaE-BookE-BookThe Clinics: Internal MedicineS013米国いいえいいえいいえいいえいいえ選択してください選択してくださいいいえいいえ選択してください
